NYSE: MD
Pediatrix Medical Group Inc Stock

$31.13-0.76 (-2.38%)
Updated Nov 17, 2026
MD Price
$31.13
Fair Value Price
N/A
Market Cap
$2.43B
52 Week Low
$17.23
52 Week High
$33.74
P/E
16.47x
P/B
2.86x
P/S
1.02x
PEG
1.37x
Dividend Yield
N/A
Revenue
$1.96B
Earnings
$150.09M
Gross Margin
26.1%
Operating Margin
12.08%
Profit Margin
7.7%
Debt to Equity
1.52
Operating Cash Flow
$227M
Beta
0.81
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

MD Overview

Pediatrix Medical Group Incorporated (formerly MEDNAX, Inc.) provides neonatal, maternal-fetal, paediatric cardiology, and related sub-speciality services. It has operations in the U.S. and Puerto Rico through affiliated professional corporations. Pediatrix Medical Group was founded in 1979 and is headquartered in Sunrise, FL.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine MD's potential to beat the market

AStrong Buy
  • Stocks with a Zen Rating of Strong Buy (A) had an average return of +28.50% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Care Facility

Industry Rating
A
MD
Ranked
#4 of 38

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$9.42A
$17.75A
$282.07A
View Top Medical Care Facility Stocks

Be the first to know about important MD news, forecast changes, insider trades & much more!

MD News

Overview

Due Diligence Score

–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MD ($31.13) is trading above its intrinsic value of $15.37, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MD is good value based on its earnings relative to its share price (16.47x), compared to the US market average (39.5x)
P/E vs Market Valuation
MD is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more MD due diligence checks available for Premium users.

Valuation

MD price to earnings (PE)

For valuing profitable companies with steady earnings

Company
16.47x
Industry
16.07x
Market
39.5x
MD is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MD is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

MD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
2.86x
Industry
5.96x
MD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MD price to earnings growth (PEG)

For valuing profitable companies with growth potential

MD is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

MD's financial health

Profit margin

Revenue
$501.4M
Net Income
$47.0M
Profit Margin
9.4%
MD's Earnings (EBIT) of $236.74M... subscribe to Premium to read more.
Interest Coverage Financials
MD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.1B
Liabilities
$1.3B
Debt to equity
1.52
MD's short-term assets ($684.08M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MD's long-term liabilities ($754.07M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$117.3M
Investing
-$4.6M
Financing
-$89.6M
MD's operating cash flow ($226.89M)... subscribe to Premium to read more.
Debt Coverage Financials

MD vs Medical Care Facility Stocks

TickerZen RatingMarket Cap1d %P/EP/B
MDA$2.43B-2.38%16.47x2.86x
ARDTA$2.50B-1.93%17.23x1.79x
AVAHA$2.54B+0.17%7.93x7.54x
ADUSA$2.27B-2.45%19.96x1.92x
BKDC$2.11B-1.79%-55.00x-53.70x

Pediatrix Medical Group Stock FAQ

What is Pediatrix Medical Group's quote symbol?

(NYSE: MD) Pediatrix Medical Group trades on the NYSE under the ticker symbol MD. Pediatrix Medical Group stock quotes can also be displayed as NYSE: MD.

If you're new to stock investing, here's how to buy Pediatrix Medical Group stock.

What is the 52 week high and low for Pediatrix Medical Group (NYSE: MD)?

(NYSE: MD) Pediatrix Medical Group's 52-week high was $33.74, and its 52-week low was $17.23. It is currently -7.74% from its 52-week high and 80.67% from its 52-week low.

How much is Pediatrix Medical Group stock worth today?

(NYSE: MD) Pediatrix Medical Group currently has 78,124,716 outstanding shares. With Pediatrix Medical Group stock trading at $31.13 per share, the total value of Pediatrix Medical Group stock (market capitalization) is $2.43B.

Pediatrix Medical Group stock was originally listed at a price of $5.34 in Dec 31, 1997. If you had invested in Pediatrix Medical Group stock at $5.34, your return over the last 28 years would have been 482.52%, for an annualized return of 6.5% (not including any dividends or dividend reinvestments).

How much is Pediatrix Medical Group's stock price per share?

(NYSE: MD) Pediatrix Medical Group stock price per share is $31.13 today (as of Nov 17, 2026).

What is Pediatrix Medical Group's Market Cap?

(NYSE: MD) Pediatrix Medical Group's market cap is $2.43B, as of Nov 18, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Pediatrix Medical Group's market cap is calculated by multiplying MD's current stock price of $31.13 by MD's total outstanding shares of 78,124,716.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.